Literature DB >> 4760050

Studies on the metabolic clearance rate, apparent distribution space and plasma half-disappearance time of unlabelled human growth hormone in normal subjects and in patients with liver disease, renal disease, thyroid disease and diabetes mellitus.

D Owens, M C Srivastava, C V Tompkins, J D Nabarro, P H Sönksen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4760050     DOI： 10.1111/j.1365-2362.1973.tb00353.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  10 in total

1.  Hormonal interrelations and their clinical significance. Growth hormone and insulin.

Authors:  P H Sönksen
Journal:  Proc R Soc Med       Date:  1975-11

Review 2.  Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.

Authors:  B Tönshoff; F Schaefer; O Mehls
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

Review 3.  Circulating growth hormone binding proteins.

Authors:  G Baumann; M A Shaw; K Amburn
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

4.  Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

Authors:  J D Veldhuis; M L Johnson; L M Faunt; M Mercado; G Baumann
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

Review 5.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

Review 6.  How safe is the treatment of uraemic children with recombinant human growth hormone?

Authors:  B Tönshoff; U Heinrich; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

7.  Regulatory mechanisms of growth hormone secretion are sexually dimorphic.

Authors:  C A Jaffe; B Ocampo-Lim; W Guo; K Krueger; I Sugahara; R DeMott-Friberg; M Bermann; A L Barkan
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

8.  Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.

Authors:  D Haffner; F Schaefer; J Girard; E Ritz; O Mehls
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  Plasma kinetics of injected recombinant chicken somatotropin in juvenile coho salmon (Oncorhynchus kisutch) using a homologous radioimmunoassay.

Authors:  N E Ted Down; H M Dye; E M Donaldson; L M Souza
Journal:  Fish Physiol Biochem       Date:  1988-05       Impact factor: 2.794

10.  Possible roles of insulin, glucagon, growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver diseases.

Authors:  E Bonora; S Orioli; C Coscelli; G Buzzelli; P Gentilini; U Butturini
Journal:  Acta Diabetol Lat       Date:  1984 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.